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Abstract
Background Gastric distension has important implications
for motility and satiety. The hypothesis of this study was
that distension affects the amplitude and duration of gastric
contraction and that these parameters are largely mediated
by efferent vagus stimulation.
Methods A novel isovolumic myograph was introduced to
test these hypotheses. The isovolumic myograph isolates
the stomach and records the pressure generated by the
gastric contraction under isovolumic conditions. Accord-
ingly, the phasic changes of gastric contractility can be
documented. A group of 12 rats were used under in vivo
conditions and isolated ex vivo conditions and with two
different gastric restraints (small and large) to determine the
effect of degree of restraint.
Results The comparison of the in vivo and ex vivo
contractility provided information on the efferent vagus
mediation of gastric contraction, i.e., the in vivo amplitude
and duration reached maximum of 12.6±2.7 mmHg and
19.8±5.6 s in contrast to maximum of 5.7±0.9 mmHg and
7.3±1.3 s in ex vivo amplitude and duration, respectively. The
comparison of gastric restraint and control groups highlights
the role of distension on in vivo gastric contractility. The
limitation of gastric distension by restraint drastically reduced
the maximal amplitude to below 2.9±0.2 mmHg.
Conclusions The results show that distension-induced
gastric contractility is regulated by both central nervous
system and local mechanisms with the former being more
substantial. Furthermore, the gastric restraint significantly
attenuates gastric contractility (decreased amplitude and
shortened duration of contraction) which is mediated by the
efferent vagus activation. These findings have important
implications for gastric motility and physiology and may
improve our understanding of satiety.
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Introduction
The stomach is largely dependent on extrinsic nervous
inputs arising from the central nervous system. These inputs
regulate the activation of gastric smooth muscles and
coordinate the digestive function of the stomach by
parasympathetic and sympathetic pathways [1, 2]. The
excitatory neurotransmitters by efferent vagus fibers (mainly
acetylcholine and tachykinins) cause rhythmic contractions
of gastric smooth muscles [3–5]. The gastric smooth
muscles exhibit the tone on which there is superimposition
of rhythmic contractions driven by cycles of membrane
depolarization and repolarization [4].
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It has been known for nearly three decades that the
gastric mechanoreceptors which respond to gastric muscu-
lar distension and contraction are implicated in postprandial
satiety, in sensing the effectiveness of a contraction to expel
contents, and in a variety of reflexes [6–8]. Electrophysi-
ological studies in different species have shown that
mechanosensitive afferent fibers located in the antrum
muscle wall respond to changes in smooth muscle trans-
mural and local tension with an increased firing rate [9–13].
Gastric distension is correlated with a firing of vagal
mechanosensitive afferent fibers which play an important
role in satiety [9, 11].
Bariatric surgery significantly reduces body weight in
obese patients and animal models and is the most effective
treatment of severe obesity [14–16]. The weight loss after
bariatric surgery is attributed to the restriction of gastric
capacity, marked reduction of hunger, malabsorption, or
regulation of appetite and satiety [13, 17–20]. We recently
developed a reverse gastric sleeve implant to mimic the
benefits of vertical sleeve gastroplasty, and a significant
weight loss and decrease in food intake were identified
[21]. Although the benefits of restrictive procedures are
acknowledged experimentally and clinically, the effect of
the restriction of gastric capacity on gastric contractility has
not been well studied.
In this study, we hypothesize that gastric restraint
mediated by mechanotransduction can acutely attenuate
gastric contractility. We introduce an isovolumic myograph
to measure gastric motility in response to intraluminal
distension. We studied the distension-induced gastric
contractility in response to intragastric inflation pressure.
We placed external restraint of two different sizes (small
and large) on the gastric wall to prevent distension of
different surface areas of the gastric wall to evaluate the
effect of degree of restraint on gastric contractility. The
comparison of contractility at in vivo with ex vivo
conditions was to assess the role of efferent vagus
activation.
Materials and Methods
The animal experiments were performed in accordance with
the guidelines of the Institute of Laboratory Animal
Research Guide, Public Health Service Policy, Animal
Welfare Act and an approved IACUC protocol by Indiana
University School of Medicine.
Animals
Twelve C571/B mice at 12 weeks of age were obtained
from Jackson Laboratory. The animals were acclimated to
the facility for approximately 1 week prior to the start of the
study. The animals were housed at 22°C under a 12-h light
and dark cycle and were given free access to tap water and
standard rodent chow. The animals were anesthetized with
xylazine (1 mg/kg, i.p.) and ketamine (9 mg/kg, i.p.) and
maintained with xylazine (0.5 mg/kg) and ketamine
(4.5 mg/kg) every half hour.
In Vivo Gastric Contractility
Under anesthesia, the abdominal skin and muscle layers of the
animal were opened to expose the stomach. The stomach was
moisturized with warm (37°C) N-2-hydroxyethylpiperazine-
N-2-ethanesulfonic acid–physiological saline solution
(HEPES-PSS in mmol/l: 119 NaCl, 4.7 KCl, 3 HEPES, 2.7
HEPES Na, 1.17 MgSO4, 1.6 CaCl, 5.5 dextrose). The
stomach was canulated with a HEPES-PSS prefilled catheter
(ID 1 mm, OD 2 mm) which was connected to the
isovolumic system (see Fig. 1). A 2-mm incision was cut
at fundus apex of the stomach through which the catheter
(OD 2 mm) was inserted into the stomach lumen. The
fundus adjacent to the incision was tied on the tube with 6-0
silk suture twice to ensure no leakage. A 2-ml HEPES-PSS
was gently injected into the stomach through the tube to
wash out the content. After careful dissection of visible vagal
nervous fibers near the stomach, the lower esophageal
sphincter and pyloric sphincter were ligated with 6-0 silk
suture. The gastric mesentery was untouched to allow the
stomach to work in a physiological enviroment maintaining
normal circulation and vagal responses. The gastric contrac-
tility was compared before imposing the restraint and after its
removal. The data were discarded if the comparison was not
within 10%.
Ex Vivo Gastric Contractility
The animal was euthanized by overanesthesia. The stomach
was excised quickly and placed in cold HEPES-PSS (4°C).
The adjacent tissue was dissected with the aid of a
stereomicroscope. The stomach was allowed to warm up
to room temperature (22°C) slowly 10–15 min and
transferred to a chamber with HEPES-PSS (22°C) of
isovolumic myograph. A 2-mm incision was cut at the
fundus apex of the stomach (fibrotic portion) and a catheter
(ID 1 mm, OD 2 mm) was inserted into the stomach lumen
through the incision. The fundus adjacent to the incision
was tied on the catheter with 6-0 suture twice to avoid
leakage. A 2-ml HEPES-PSS was gently injected into the
stomach through the catheter to wash out the gastric
content. Following drainage, the lower esophageal sphincter
and pyloric sphinter were ligated with 6-0 silk suture. The
stomach in the chamber was warmed to 37°C slowly (15–
20 min) and equilibrated for 30 min at a basal intragastric
pressure of about 2 mmHg before distension.
OBES SURG (2010) 20:1544–1551 1545
Isovolumic Myograph
An isovolumic myograph (Fig. 1a) consists of a chamber
with a catheter on one side wall of the chamber which
bridges the gastric lumen to inflation flask and pressure
transducer [22]. A 50-ml inflation flask with PSS
(connected to a pressure regulator) inflates the stomach to
the desired pressure. The catheter, a solid state pressure
transducer (SPR-524, Microtip catherter transducer, Millar
Inc, TX, USA), a tube to the inflation flask, and a
compensatory microsyringe were assembled in a four-way
connector. A compensatory microsyringe (50 μl gastight
microsyringe, UltraMicroPump III, and Micro 4TM micro-
syringe control, World Precision Instruments, USA) was
used to stabilize the baseline of the pressure since water
transport across the gastric wall reduces the intragastric
pressure. The clamping of the tube between the inflation
flask and the four-way connector achieves isovolumic
conditions, i.e., intragastric volume is constant. As the
stomach was inflated to a desired pressure (e.g., 5,
10 mmHg, etc.), the clamp was closed and the gastric
contraction or relaxation was reflected by the variation of
intragastric pressure recorded with a solid state pressure
transducer. The isovolumic system records the periodic
contractions of the stomach by the periodic variations of
pressure.
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Gastric Contractility in Response to Mechanical
Stimulation
The mechanical stimulation of the stomach in this study
was induced by an intragastric inflation pressure. The
gastric contraction was quantified by the intragastric
presssure under isovolumic condition, and the contractility
was characterized with the amplitude and period of the
pressure waveforms. The stomach was inflated to a desired
pressure by a pressure regulator connected to a flask. The
clamping of the tube between the inflation flask and the
four-way connector maintained a constant volume of
solution in the gastric lumen (isovolumic condition). The
compensatory microsyringe maintains isovolumic condi-
tions at an infusion rate of 1–3 μl/min. The data were
discarded if the rate was larger than 10 μl/min since this
implied damage (leakage) of the gastric wall. At isovolumic
conditions, the variations of intragastric pressure were
recorded with a data acquisition system (Biopac, MP100,
Houston, TX, USA). The amplitude, frequency, and
contractile duration of pressure waveforms were analyzed
to characterize the gastric contractility.
Gastric Restraint
There were two types of loosely fitting restraints used in
this study. The small restraint was a sector made of stainless
steel wire (ϕ0.71 mm) and able to be closed to a circle with
an inner diameter of 5.8 mm. The wire cycle was placed
between the pyloric antrum and gastric body (Fig. 1c). A
large restraint was made of plastic tube to study the effect
of covered area of restrtaint on the gastric contraction. A
cap of the tube was removed (semi-cylinder) to allow
gastric mesentery pass free (Fig. 1b). The dimensions of the
tube were 12.5 mm in length, 6 mm in internal diameter,
and 2 mm in wall thickness. The width of the semi-cylinder
is about 1 mm. The semi-cylinder was longitudinally
opened up to a sector with the aid of a forceps. The semi-
cylinder was passed through the gastric body. The forceps
was released to allow the semi-cylinder to fully wrap the
stomach. The semi-cylinder was circumferentially tied with
a 6-0 silk suture to restraint the stomach into the internal
space of the semi-cylinder when the stomach was inflated
(Fig. 1b). The large restraint covered the side area of the
stomach and limited the stretch on the gastric side wall
despite an increase in intragastric pressure. The non-
covered gastric wall on the two ends was distended during
the increase in intragastric pressure.
Protocol of Mechanical Stimulation
The intragastric pressure was increased stepwise to 2, 5, 10,
15, 20, 30, 40, and 50 mmHg at a rate of 0.06 ml/min,
respectively. The gastric contraction at isovolumic condi-
tion was recorded as the variation of the pressure at each
individual inflation pressure. This protocol was applied to
both in vivo and ex vivo stomach with or without gastric
restraint. In the experiment of ex vivo stomach, acetylcho-
line (10–6 mol/l) was used to elicit non-neuroactive
contraction of gastric smooth muscle at intragastric pressure
of 50 mmHg to evalute contractility of gastric smooth
muscle.
Data Analysis and Statistics
Figure 1d illustrates the definition of the parameters used in
the analysis. The gastric contractile amplitude (A) was
indicated by the amplitude of the variation of pressure. The
gastric contractile period (Δt) was defined as the interval
from one pressure waveform to the next pressure wave-
form. The gastric contractile duration (Δtd) was defined as
the interval from pressure rise to fall.
The data were presented as mean ± SD and significant
differences between groups were determined by Student’s
t test. Significant differences between the in vivo, ex vivo,
and restraint groups were determined by the use of analysis
of variance (ANOVA) between groups. A probability of P<
0.05 was considered indicative of a statistically significant
difference.
Results
The intragastric pressure and gastric volume in both in vivo
and ex vivo are shown in Fig. 2, which reflects the global
distension (compliance) of the stomach. The in vivo gastric
volume was significantly different from the ex vivo
volume. The ex vivo gastric volume increased in low
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 10 20 30 40 50
Intraluminal Pressure (mmHg)
In
fla
te
d 
V
ol
um
e 
(m
l)
Ex vivo
In vivo
Ex vivo + small restraint
In vivo + small restraint
Ex vivo + large restraint
In vivo + large restraint
Fig. 2 The relationship between gastric capacity (volume) and
inflation pressure for various conditions. The statistical analysis
(ANOVA): P<0.05 between ex vivo and in vivo. P<0.05 among in
vivo, in vivo + small restraint, and in vivo + large restraint. P<0.05
among ex vivo, ex vivo + small restraint, and ex vivo + large restraint.
P>0.05 between in vivo + small restraint and ex vivo + small
restraint. P>0.05 between in vivo + large restraint and ex vivo + large
restraint
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pressure range (5–20 mmHg) while in vivo gastric volume
increased almost linearly. The small restraint approximately
reduced half of the gastric volume at high pressure range.
The large restraint limited the gastric volume at about 30%
of maximum.
The intragastric pressure waveforms during gastric
contraction are shown in Fig. 3. The variation of the
pressure reflects the gastric contractility which is charac-
terized by three parameters: contractile amplitude, duration,
and period. The in vivo amplitude of gastric contraction
increased from 1.6 to 12.5 mmHg when the inflation
pressure changed from 2 to 30 mmHg (Fig. 3a), respec-
tively. Clearly, both the small (Fig. 3b) and large (Fig. 3c)
restraints significantly attenuated the amplitude of gastric
pressure generation (contractility).
The contractility relation is shown in Fig. 4 both as a
function of inflation pressure (Fig. 4a) and volume
(Fig. 4b). The contractility increased with an increase in
inflation pressure or volume and reached a maximum for
the in vivo condition. The in vivo amplitude then decreased
from 12.5 to 3.3 mmHg (Fig. 4a) when the inflation
pressure was further increased from 30 to 50 mmHg. In ex
vivo, the gastric contractile amplitude was significantly
lower than that in in vivo at every inflation pressure. At
50 mmHg inflation pressure, the ex vivo contraction was
completely abolished. We found that the contraction
stimulated by the external administration of ACh (the right
columns in Figs. 3 and 4), however, was still high. This
suggests that the inhibition of gastric contraction under high
distension is regulated by efferent nerves since gastric
smooth muscle maintains contractility in response to ACh.
The gastric restraint was applied externally to restrict
gastric expansion during inflation. The large restraint
covered over 80% of the external surface of the stomach
and completely blocked the ex vivo gastric contraction and
suppressed in vivo gastric contractions. To verify that the
gastric nerves were not damaged during placement of large
restraint, the contractility was measured again after removal
of restraint. We found that the contractility remained at 95%
to 100% of that before the application of the large restraint.
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The small restraint covered <10% of the external surface
of the stomach. It is interesting that the inhibitory effects of
the small restraint on gastric contraction were similar to
those of the large restraint. In ex vivo experiments, the
gastric contraction was completely inhibited by the large
and small restraints (data not shown). But the ACh-induced
contraction was similar to that of control (the right columns
in Figs. 3, 4, and 5), which indicates that the agonist-
induced contractility of gastric smooth muscle was not
affected and the gastric restraint may block efferent
activation of gastric response.
The durations of the gastric contractility in vivo and ex
vivo and under two gastric restraint conditions are
presented in Fig. 5 as a function of pressure (a) and volume
(b). The duration indicates the sustained interval of a single
contraction wave. The in vivo duration was significantly
larger than the ex vivo duration when the inflation pressure
was below 35 mmHg or inflation volume was below
0.7 ml. The in vivo duration reached a maximum when
inflation pressure increased from 10 to 20 mmHg (inflation
volume from 0.3 to 0.5 ml). The ex vivo duration did not
significantly change with the inflation. The large restraint
blocked the change of in vivo duration with the inflation
pressure or volume. The small restraint did not significantly
affect the in vivo duration. The maximum duration with
small restraint occurred at 10 mmHg of inflation pressure or
0.2 ml of inflation volume, which was lower than that
without gastric restraint (~15 mmHg).
The period of the gastric contractility in vivo and ex vivo
is shown in Fig. 6 as a function of pressure (a) and volume
(b). The results showed that the period was similar in both
in vivo and ex vivo preparation and increased with
inflation. The gastric restraint eliminated the increase of
period following inflation.
Discussion
An isovolumic myograph was used to assess gastric
contractility in terms of amplitude, duration, and period.
The gastric restraint was shown to attenuate the mechanical
stimulation-induced gastric contractility. The in vivo prep-
aration was designed to detect the efferent neurogenic
contraction and ex vivo preparation was designed to
measure the efferent-independent contraction. The in vivo
contractile amplitude and duration were significantly larger
than those in ex vivo, indicating that contractile amplitude
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The statistical analysis (ANOVA) is as follows: P<0.05 between ex
vivo and in vivo; P<0.05 among in vivo, small restraint, and large
restraint. The data for ex vivo small and large restraints were not
shown since the amplitude of pressure wave was zero
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and duration may be efferent neurogenic. The similar
period in in vivo and ex vivo preparation indicates that
contractile period may be efferent-independent. The gastric
restraint drastically attenuates the in vivo amplitude and
duration of efferent neurogenic contraction, whereas the
gastric restraint did not alter the period of the contraction.
Gastric contractility is closely coupled to the mechano-
sensitivity located in the gastric wall [12, 23, 24]. The
myogenic response of the gastric smooth muscle and
efferent neurogenic contraction are regulated by mechanor-
eceptors: afferent and efferent vagus nerves [1, 6, 9, 11, 12,
23, 24]. The relation between afferent vagus signals and
gastric distension was identified decades ago [6, 9, 11, 12].
The mechanoreceptors in the gastric wall are primary
sensors of mechanical stimulation [9, 23]. The efferent
(motor) vagus signals are responses of the central nervous
system to the afferent (sensory) vagus stimulation [2]. One
of the physiological functions of efferent vagus signals is to
regulate gastric contractility. Hence, the gastric contractility
reflects the activation of the efferent vagus nerve.
In the present study, we evaluated gastric contractility in
ex vivo preparation which excludes efferent vagus regula-
tion. In the ex vivo stomach, the nerve fibers are excised
and damaged, and hence, there is a loss of efferent vagus
signals which appears to be significant for mechanical
distension-induced contractility. The ex vivo contractility of
the gastric smooth muscle was significantly attenuated due
to the absence of efferent vagus signals. The strong in vivo
contractility reflects the efferent vagus activation in
response to mechanical stimulation sensed by afferent
vagus nerves. The role of duration is interesting since it
may reflect the efferent vagus activation. The duration of
in vivo contraction varies with mechanical stimulation,
whereas the duration of ex vivo contraction is largely
unchanged in response to mechanical stimulation. The latter
implies that the duration is regulated by the central nervous
system. In contrast, the period seems to be independent of
efferent vagus activation since both in vivo and ex vivo
periods increase during the increase in distension. It appears
that the contractility (Fig. 4) and duration (Fig. 5) which are
dependent on efferent vagus activation are affected by
gastric restraint, whereas the period (Fig. 6) is independent
of efferent vagus activation.
Bariatric surgery, by restriction of gastric capacity or
malabsorption, has been used to limit the amount of food
intake in obesity [8, 25–28]. Weight loss and subsequent
ameliorations in cardiovascular system are the major
benefits of bariatric surgery [29–32]. Effects on the
gastrointestinal hormonal levels and neurologic reflex
response have been proposed to contribute to the mecha-
nism of weight loss after bariatric surgery [6, 8, 12, 17–20,
33–35]. The present study shows that gastric restraint
significantly attenuates gastric contractility and the decrease
in the contractility is due to the downregulation of efferent
vagus activation (Figs. 3 and 4). Our present findings
suggest that gastric restraint may not only reduce gastric
capacity but also compromises the gastric motility and
delays gastric emptying. Since the peak of duration of the
small restraint shifts to smaller inflation volume, this
implies that efferent vagus inactivation is engaged at
smaller filling volumes.
Some limitations of the present model deserve mention.
Although the isovolumic myograph was used to evaluate
the gastric global contractility, the regional contraction was
not measured. The gastric tone (basal pressure) in the
fundus and upper body was not characterized in the present
study. Furthermore, the gastric contractile wave is generat-
ed in the lower stomach. Finally, the ligation on esophageal
and pyloric sphincters may reduce the gastric contractility
because of tiny nerve fibers in the sphincters. The
variations of the contractility from animal to animal may
be attributed to of the injury of nerves from ligation.
Although the efferent vagus activation was evaluated
mechanically, the nerve activation should be recorded
electrically in future studies to further validate the present
observation.
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In conclusion, we introduced a novel isovolumic myo-
graph to understand the contractility of the stomach. The in
vivo and ex vivo gastric contractility in response to
distension (inflation) provides evidence that gastric motility
can be regulated by the central nervous system. The gastric
restraint can attenuate gastric contractility (amplitude and
duration of contraction), which is mediated by efferent
vagus activation. The large restraint blocking gastric
contractility more than the small restraint implies that the
covered area of gastric restraint affects gastric motility. This
study provides a better understanding of the role of gastric
distension and its relation to the central nervous system.
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